Reduction of leukemic burden via bone‐targeted nanoparticle delivery of an inhibitor of C‐chemokine (C‐C motif) ligand 3 (CCL3) signaling

Ackun‐Farmmer, M. A., Soto, C. A., Lesch, M. L., Byun, D., Yang, L., Calvi, L. M., Benoit, D. S. W. and Frisch, B. J.  Reduction of leukemic burden via bone‐targeted nanoparticle delivery of an inhibitor of C‐chemokine (C‐C motif) ligand 3 (CCL3) signaling.  The FASEB Journal. 2021; 35(4).  doi: 10.1096/fj.202000938rr

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.